Abstract
Post-traumatic stress disorder (PTSD) is a severe mental health condition that arises as a result of exposure to extreme or life-threatening events and is accompanied by disturbances in emotional, cognitive, behavioural and neuroendocrine regulation. Although psychological trauma is the primary aetiological factor in PTSD, the development of a clinically significant disorder is observed only in a proportion of individuals, indicating the important role of genetic predisposition and individual biological vulnerability.The aim of this review was to summarise the current published data on the role of single-nucleotide polymorphisms of genes in the pathogenesis of PTSD and their significance in the formation of the individual’s response to stress.Materials and methods. This study involved a systematic review of scientific publications available in the international databases PubMed, Scopus, Web of Science and Google Scholar. Particular attention was paid to genetic variants that regulate the functioning of the hypothalamic–pituitary–adrenal axis, as well as the serotonergic, dopaminergic, neurotrophic and neuropeptide systems.Results. The role of polymorphisms in the FKBP5, NR3C1, CRHR1, SLC6A4, DRD2, COMT, BDNF, FAAH, OXTR and NPSR genes in the development of PTSD, the emergence of anxiety symptoms, sleep disturbances, emotional dysregulation and impaired fear extinction was analysed. It was established that epigenetic mechanisms, in particular gene methylation and the interaction of hereditary factors with early traumatic experiences, play a significant role in the development of the disorder.Conclusions. The obtained data confirm the polygenic nature of PTSD and indicate the potential for using genetic markers to predict the risk of developing the condition, for early diagnosis, and for developing personalised approaches to the prevention and treatment of PTSD.